CAPLACIZUMAB is used for treatment of?
CAPLACIZUMAB: a. It is a Von - Willebrand factor (vWF) directed antibody fragment b. Target the A1 - domain of vWF, and inhibits the interaction between vWF and platelets, thereby reducing both vWF - mediated platelet adhesion and platelet consumption. c. Used for treatment of acquired Thrombotic Thrombocytopenic Purpura (aTTP)
Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
Plaque Psoriasis
Breast cancer
Bladder cancer
Hematology